Neuroprotective Effect of Gold Nanoparticles Composites in Parkinson's Disease Model

Kaikai Hu,Xiaohui Chen,Wuya Chen,Lingkun Zhang,Jian Li,Jialin Ye,Yuxiao Zhang,Li Zhang,Chu-Hua Li,Liang Yin,Yan-Qing Guan

DOI: https://doi.org/10.1016/j.nano.2018.01.020

IF: 6.458

2018-01-01

Nanomedicine Nanotechnology Biology and Medicine

Abstract:Parkinson's disease (PD) is second most common neurodegenerative disorder worldwide. Although drugs and surgery can relieve the symptoms of PD, these therapies are incapable of fundamentally treating the disease. For PD patients, over-expression of α-synuclein (SNCA) leads to the death of dopaminergic neurons. This process can be prevented by suppressing SNCA over-expression through RNA interference. Here, we successfully synthesized gold nanoparticles (GNP) composites (CTS@GNP-pDNA-NGF) via the combination of electrostatic adsorption and photochemical immobilization, which could load plasmid DNA (pDNA) and target specific cell types. GNP was transfected into cells via endocytosis to inhibiting the apoptosis of PC12 cells and dopaminergic neurons. Simultaneously, GNP composites are also used in PD models in vivo, and it can successfully cross the blood-brain barrier by contents of GNP in the mice brain. In general, all the works demonstrated that GNP composites have good therapeutic effects for PD models in vitro and in vivo.